The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor
- PMID: 8977135
- DOI: 10.1016/s0304-3940(96)13212-2
The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor
Abstract
The effect of modafinil on endogenous gamma-aminobutyric acid (GABA) release in the medial preoptic area (MPA) and posterior hypothalamus (PH) and the role of local 5-HT3 receptors in this effect was investigated in the awake rat using in vivo microdialysis. Modafinil (30-100 mg/kg i.p.) dose-dependently decreased GABA release from the MPA, while only the 100 mg/kg dose markedly reduced GABA release in the PH. The modafinil (100 mg/kg) induced inhibition of GABA release in the MPA and the PH was partially counteracted by the 5-HT3 receptor antagonist MDL72222 (1 microM) when perfused locally alone or together with the non-selective 5-HT receptor antagonist methysergide (1 microM). Thus, the reduction of GABA transmission induced by modafinil in the MPA and in the PH, at least in part, involves local 5-HT3 receptors. The GABA release inhibition by modafinil in the above areas may be relevant for its vigilance promoting action.
Similar articles
-
The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade.Neuropsychopharmacology. 1999 Apr;20(4):346-56. doi: 10.1016/S0893-133X(98)00085-2. Neuropsychopharmacology. 1999. PMID: 10088135
-
Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression.J Neurosci Res. 2002 Apr 1;68(1):107-12. doi: 10.1002/jnr.10196. J Neurosci Res. 2002. PMID: 11933055
-
Effects of the vigilance promoting drug modafinil on the synthesis of GABA and glutamate in slices of rat hypothalamus.Neurosci Lett. 1999 Jan 15;259(3):181-5. doi: 10.1016/s0304-3940(98)00905-7. Neurosci Lett. 1999. PMID: 10025588
-
The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus.Neuroreport. 1997 Sep 8;8(13):2883-7. doi: 10.1097/00001756-199709080-00016. Neuroreport. 1997. PMID: 9376524
-
Action of modafinil through histaminergic and orexinergic neurons.Vitam Horm. 2012;89:259-78. doi: 10.1016/B978-0-12-394623-2.00014-7. Vitam Horm. 2012. PMID: 22640618 Review.
Cited by
-
Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder.CNS Drugs. 2005;19(9):785-803. doi: 10.2165/00023210-200519090-00005. CNS Drugs. 2005. PMID: 16142993 Review.
-
Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.J Clin Sleep Med. 2013 Aug 15;9(8):751-7. doi: 10.5664/jcsm.2912. J Clin Sleep Med. 2013. PMID: 23946704 Free PMC article. Clinical Trial.
-
Psychostimulants and cognition: a continuum of behavioral and cognitive activation.Pharmacol Rev. 2013 Dec 16;66(1):193-221. doi: 10.1124/pr.112.007054. Print 2014. Pharmacol Rev. 2013. PMID: 24344115 Free PMC article. Review.
-
Hypothalamic arousal regions are activated during modafinil-induced wakefulness.J Neurosci. 2000 Nov 15;20(22):8620-8. doi: 10.1523/JNEUROSCI.20-22-08620.2000. J Neurosci. 2000. PMID: 11069971 Free PMC article.
-
Ethanol-induced alterations of amino acids measured by in vivo microdialysis in rats: a meta-analysis.In Silico Pharmacol. 2013 May 17;1:7. doi: 10.1186/2193-9616-1-7. eCollection 2013. In Silico Pharmacol. 2013. PMID: 25505652 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
